Scientific Poster Presentations

---

"SER-109, an Investigational Microbiome Drug for Recurrent Clostridioides difficile Infection: Lessons Learned from a Phase 2 Trial."

Poster Provided by:

Seres Therapeutics

Poster Presentation by:  

Christopher Ford, Ph.D.

Senior Director, R&D 

Computational Microbiome Sciences 

"A Rationally-Designed Consortium (VE303) For Prevention of Clostridioides difficile Recurrence." 

Poster Provided by:

Vedanta BioSciences

Poster Presentation by:

Jeffrey Silber, MD, Chief Medical Officer

Bernat Olle, Ph.D., Chief Executive Officer

"Prevention Of Recurrent Clostridioides difficile Infection at Two Years After Treatment with Investigational Microbiota-Based Drug RBX2660: Efficacy, Durability, Microbiome Changes, and Participant Demographics of a Phase 2 

Open-Label Clinical Trial."

Poster Provided by

Rebiotix (a Ferring Company)

Poster Presentation by: 

Courtney Jones

Associate Director, Marketing and Communications

“TECHLAB QUIK CHEK EIA Technology.”  

Poster Provided by

TechLab

"A Phase 2 Clinical Trial Evaluating  a Novel Antibiotic Against a  CDI." 

Poster Provided by

Deinove 

Poster Presentation by: 

Yannick Pletan, MD, MSc, HEC

Chief Medical Officer

"Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for

Clostridioides diffiicle Infection."  

Poster Provided by

Progenabiome

Poster Presentation by 

Sabine Hazan Steinberg, MD

Gastroenterology/Hepatology/Internal Medicine 

"DAV132 Protects the Intestinal Microbiota of Patients Treated with Fluoroquinolones.

A European Phase II Randomized Controlled Trial (SHIELD)."

Poster Presentation provided by

DaVolterra

Poster Presentation by:

Jean DeGunzburg, Ph.D. 

Chief Scientific Officer

"An Investigational Orally Administered Microbiome Drug, CP101, for the Prevention of Recurrent C. difficile Infection: A Randomized, Placebo-Controlled, Multi-Center Trial (PRISM3) ."

Poster Provided by:

Finch Therapeutics

Poster Presentation by:

Jessica R. Allegretti, MD, MPH (Brigham & Women's Hospital and Harvard Medical School, Boston) 

"Evaluation Of a Novel Antimicrobial Textile Intervention For Inclusion In An Infection Control Program Through a Retrospective Analyses Of 

Hospital-Acquired Infection (HAI) Rates."

Poster Provided by 

Applied Silver 

Poster Presentation by

Dr. Priya  Balachandran, Ph.D.

Chief Operations Officer

 UV-C is a powerful tool to kill pathogens, but how do you know if you’ve delivered a lethal dose?

Join Wendy Brady as she explains how UVC Dosimeters

by Intellego Technologies 

providing visible evidence of successful ultraviolet disinfection, so you can truly SEE you’ve hit your mark to kill  C. diff. spores, MRSA, and even

 SARS-CoV-2.